Peer Review reports
From: MiR-34a affects dexmedetomidine-inhibited chronic inflammatory visceral pain by targeting to HDAC2
| Original Submission | ||
|---|---|---|
| 24 Apr 2019 | Submitted | Original manuscript |
| 21 May 2019 | Reviewed | Reviewer Report - Martin Kaczocha |
| 27 May 2019 | Reviewed | Reviewer Report - Nebojsa Nick Knezevic |
| 14 Jun 2019 | Author responded | Author comments - Meng Liang |
| Resubmission - Version 2 | ||
| 14 Jun 2019 | Submitted | Manuscript version 2 |
| 28 Jun 2019 | Reviewed | Reviewer Report - Nebojsa Nick Knezevic |
| 30 Jun 2019 | Reviewed | Reviewer Report - Martin Kaczocha |
| 9 Jul 2019 | Author responded | Author comments - Meng Liang |
| Resubmission - Version 3 | ||
| 9 Jul 2019 | Submitted | Manuscript version 3 |
| Publishing | ||
| 10 Jul 2019 | Editorially accepted | |
| 19 Jul 2019 | Article published | 10.1186/s12871-019-0801-z |
You can find further information about peer review here.